← Back to guidelines
Cardiology71 papers

Non-tuberculous mycobacterial pneumonia

Last edited: 4/15/2026

Overview

Non-tuberculous mycobacterial (NTM) pneumonia is a chronic respiratory infection caused by mycobacteria other than Mycobacterium tuberculosis, often affecting immunocompetent individuals with varying degrees of severity 1.

Diagnosis

  • Clinical Presentation: Subacute or chronic respiratory symptoms, including cough, fever, and weight loss 1.
  • Imaging: Chest X-ray or CT showing characteristic infiltrates, nodules, or cavities 1.
  • Microbiological Confirmation: Sputum or bronchoalveolar lavage cultures identifying NTM species 1.
  • Serological Tests: Not routinely recommended for diagnosis 1.
  • Management

  • Antibiotic Therapy: Prolonged courses, often tailored to the specific NTM species identified (e.g., macrolides, fluoroquinolones, aminoglycosides) 1.
  • Duration: Treatment duration varies but typically ranges from several months to over a year, depending on response and species 1.
  • Surgical Intervention: Considered in cases of abscess formation or complications refractory to medical management 1.
  • Observation: For asymptomatic or minimally symptomatic cases, close monitoring without immediate antibiotic therapy may be appropriate 1.
  • Special Populations

  • Pediatrics: Management focuses on expectant or prolonged antibiotic therapy, with surgery reserved for complications 1.
  • Comorbidities: Specific management adjustments may be necessary based on underlying conditions, though detailed guidelines are not provided in the abstract 1.
  • Key Recommendations

  • Diagnostic Work-up: Include imaging studies and microbiological confirmation through cultures 1 (Evidence: Expert opinion).
  • Treatment Goals: Aim for resolution of symptoms and eradication of NTM infection, with prolonged antibiotic therapy as a cornerstone 1 (Evidence: Expert opinion).
  • Surgical Consideration: Evaluate surgical intervention for complications such as abscesses not responding to medical treatment 1 (Evidence: Expert opinion).
  • References

    1 Roy CF, Balakrishnan K, Boudewyns A, Cheng A, Chun RH, Daniel SJ et al.. International Pediatric Otolaryngology Group: Consensus guidelines on the diagnosis and management of non-tuberculous mycobacterial cervicofacial lymphadenitis. International journal of pediatric otorhinolaryngology 2023. link

    Original source

    1. [1]
      International Pediatric Otolaryngology Group: Consensus guidelines on the diagnosis and management of non-tuberculous mycobacterial cervicofacial lymphadenitis.Roy CF, Balakrishnan K, Boudewyns A, Cheng A, Chun RH, Daniel SJ et al. International journal of pediatric otorhinolaryngology (2023)

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG